Image

Use of the Napoleon to Improve Polyp Measurement in Gastroenterology Fellows

Recruiting
45 years of age
Both
Phase N/A

Powered by AI

Overview

This is a clinical trial assessing gastroenterology fellows' accuracy of colonic polyp measurement using a Micro-Tech Endoscopic Polyp Measurement Device named Napoleon. The study will evaluate the feasibility of Napoleon as a polyp measurement device. Investigators will collect data on inpatient and outpatient colonoscopies performed by fellows at NYU Langone Health, NYU Langone Hospital Brooklyn, Bellevue Hospital Center, and Manhattan VA Medical Center from May 2021 - May 2022 for 150 patients. Investigators will include all colonoscopies with polyps done in adults age 45 and above. For each colonoscopy, a fellow will first visually estimate the polyp size and then measure the polyp with Napoleon. Investigators will calculate the difference in polyp measurement between visual assessment and using Napoleon for each fellow year and compare differences among fellow years. Investigators will evaluate for changes in fellows' accuracy of polyp measurement with subsequent uses of Napoleon. Investigators will determine the proportion of cases with a change in the recommended surveillance interval based on polyp size. A survey will be given to all fellows to assess the level of ease with using Napoleon.

Eligibility

Patients

Inclusion Criteria:

  1. Adult age 45 and above
  2. Undergoing a colonoscopy performed by a gastroenterology fellow
  3. Willingness and ability to provide informed consent

Exclusion Criteria:

  1. History of not tolerating prior colonoscopies well or difficult colonoscopies (e.g. high sedative requirement)
  2. Undergoing a diagnostic colonoscopy for inflammatory bowel disease or other known inflammatory/infectious process
        An individual who meets any of the following criteria during the colonoscopy will be
        excluded from participation in this study:
          1. Colonoscopy without polyps
          2. Polyps not removed in entirety
          3. Polyps with indeterminate size
        An individual who meets any of the following criteria after the colonoscopy will be
        excluded from participation in this study:
        1. Hyperplastic or non-adenomatous polyps on pathology report
        Fellows
        Inclusion Criteria:
          1. NYU gastroenterology fellow
          2. Willingness and ability to provide informed consent
        Exclusion Criteria:
        1. Not deemed to be medically trained and ready to perform a colonoscopy by supervising
        gastroenterology attending

Study details

Colonic Polyp

NCT04858477

NYU Langone Health

23 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.